PL1694320T3 - Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności - Google Patents

Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności

Info

Publication number: PL1694320T3
Authority: PL; Poland
Prior art keywords: acid; hypersensitivity; treatment; hyperreactivity; medicament
Prior art date: 2003-12-19

Application number

PL04806247T

Other languages

English (en)

Inventor

Frederick W Cain

Wiro Stam

Ulrike Schmid

Geoff Collins

Original Assignee

Lipid Nutrition Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-19

Filing date

2004-12-17

Publication date

2008-11-28

2004-12-17 Application filed by Lipid Nutrition Bv filed Critical Lipid Nutrition Bv

2008-11-28 Publication of PL1694320T3 publication Critical patent/PL1694320T3/pl

Links

WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 title abstract 3
MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 title abstract 3
MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 title abstract 3
229940096998 ursolic acid Drugs 0.000 title abstract 3
PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 title abstract 3
206010020751 Hypersensitivity Diseases 0.000 title abstract 2
208000026935 allergic disease Diseases 0.000 title abstract 2
230000035874 hyperreactivity Effects 0.000 title abstract 2
230000009610 hypersensitivity Effects 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
239000000203 mixture Substances 0.000 title 1
MXEMKMNFLXVQBW-UHFFFAOYSA-N oleanoic acid Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MXEMKMNFLXVQBW-UHFFFAOYSA-N 0.000 title 1
239000002253 acid Substances 0.000 abstract 4
150000007513 acids Chemical class 0.000 abstract 4
JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 abstract 2
YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 abstract 2
229940100243 oleanolic acid Drugs 0.000 abstract 2
HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 abstract 2
239000000463 material Substances 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Immunology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

PL04806247T 2003-12-19 2004-12-17 Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności PL1694320T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP03258087		2003-12-19
PCT/GB2004/005453 WO2005058302A1 (en)	2003-12-19	2004-12-17	Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity
EP04806247A EP1694320B1 (en)	2003-12-19	2004-12-17	Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity

Publications (1)

Publication Number	Publication Date
PL1694320T3 true PL1694320T3 (pl)	2008-11-28

Family

ID=34684630

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04806247T PL1694320T3 (pl)	2003-12-19	2004-12-17	Zastosowanie kompozycji zawierających kwas oleanolowy i kwas ursolowy do wytwarzania leku do leczenia nadwrażliwości i nadreaktywności

Country Status (9)

Country	Link
US (1)	US20110229563A1 (pl)
EP (1)	EP1694320B1 (pl)
JP (1)	JP2007514727A (pl)
CN (1)	CN1893937B (pl)
AT (1)	ATE400262T1 (pl)
DE (1)	DE602004014974D1 (pl)
ES (1)	ES2311177T3 (pl)
PL (1)	PL1694320T3 (pl)
WO (1)	WO2005058302A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20170049623A (ko) *	2010-11-22	2017-05-10	피닉스 바이오테크놀러지 인코포레이티드.	네리움 종 또는 테베티아 종의 추출물로 신경학적 병태를 치료하는 방법
CN108902893B (zh)	2013-02-08	2022-02-25	通用磨坊公司	低钠食品
KR101645963B1 (ko) *	2014-05-13	2016-08-08	주식회사한국야쿠르트	사과박(apple pomace)으로부터 우르솔릭산을 고효율로 추출하는 방법 및 그 방법에 의해 추출된 우르솔릭산을 유효성분으로 함유하는 식품조성물
CN104610417B (zh) *	2015-02-16	2016-05-11	白心亮	一种从山楂中提取熊果酸和齐墩果酸的方法
CN111417384A (zh) *	2017-09-14	2020-07-14	菲尼克斯生物技术公司	用于治疗神经系统病况的方法和改进的神经保护性组合物
DE102018217341A1 (de) *	2018-10-10	2020-04-16	Katjes Fassin GmbH.+Co. Kommanditgesellschaft	Mit apfelwachs beschichtetes bonbon
JP7276745B2 (ja) *	2019-06-14	2023-05-18	地方独立行政法人青森県産業技術センター	リンゴ由来トリテルペノイド含有組成物製造方法、ウルソール酸製造方法、およびオレアノール酸製造方法
CN112704663B (zh) *	2020-12-18	2022-07-19	吉林农业科技学院	一种枇杷叶熊果酸乳膏的制备方法
CN114129572B (zh) *	2021-12-16	2023-04-07	南开大学	一种协同抑制汉防己甲素诱导的药源性肝损伤的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03287530A (ja) *	1990-03-31	1991-12-18	Snow Brand Milk Prod Co Ltd	免疫抑制剤
JPH1112178A (ja) *	1997-06-23	1999-01-19	Dainippon Pharmaceut Co Ltd	オレアノール酸系抗掻痒剤
DE60114708T2 (de) *	2000-06-05	2006-07-20	Loders Croklaan B.V.	Ursolsäure und Oleanolsäure enthaltende Mischungen
DE60204078T2 (de) *	2001-04-09	2006-01-26	Loders Croklaan B.V.	Konzentrat von Triterpenen
JP5081354B2 (ja) *	2001-11-07	2012-11-28	株式会社ナリス化粧品	ＩｇＥ産生抑制剤

2004
- 2004-12-17 DE DE602004014974T patent/DE602004014974D1/de not_active Expired - Lifetime
- 2004-12-17 PL PL04806247T patent/PL1694320T3/pl unknown
- 2004-12-17 WO PCT/GB2004/005453 patent/WO2005058302A1/en not_active Ceased
- 2004-12-17 US US10/583,151 patent/US20110229563A1/en not_active Abandoned
- 2004-12-17 JP JP2006544564A patent/JP2007514727A/ja active Pending
- 2004-12-17 AT AT04806247T patent/ATE400262T1/de not_active IP Right Cessation
- 2004-12-17 CN CN2004800379582A patent/CN1893937B/zh not_active Expired - Fee Related
- 2004-12-17 EP EP04806247A patent/EP1694320B1/en not_active Expired - Lifetime
- 2004-12-17 ES ES04806247T patent/ES2311177T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2007514727A (ja)	2007-06-07
CN1893937A (zh)	2007-01-10
ES2311177T3 (es)	2009-02-01
EP1694320A1 (en)	2006-08-30
DE602004014974D1 (de)	2008-08-21
US20110229563A1 (en)	2011-09-22
ATE400262T1 (de)	2008-07-15
CN1893937B (zh)	2011-01-12
WO2005058302A1 (en)	2005-06-30
EP1694320B1 (en)	2008-07-09

Publication	Publication Date	Title
EP4533963A3 (en)	2025-06-25	Moist oral compositions
MY159379A (en)	2016-12-30	Composition for human and/or animal nutrition, uses thereof and yeasts
MXPA05009933A (es)	2005-11-04	Composiciones que comprenden acidos grasos y aminoacidos.
WO2006007136A3 (en)	2006-10-12	Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
AU2002322421A1 (en)	2003-02-17	Improved edible film formulations containing maltodextrin
EP3434687A3 (en)	2019-02-20	Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
MXPA04004842A (es)	2004-08-02	Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
SG146648A1 (en)	2008-10-30	Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
MY143795A (en)	2011-07-15	Tetrahydropyridoindole derivatives
MX2009005308A (es)	2009-05-28	Composiciones que comprenden peroxido de benzoilo, al menos un derivado del acido naftoico y al menos un compuesto del tipo polimeros de poliuretano o derivados de estos y sus usos.
WO2002083879A3 (en)	2002-12-12	Immunotherapy based on dendritic cells
MY155299A (en)	2015-09-30	Oral dosage composition
WO2000053149A3 (en)	2000-12-28	Method and composition for administering a cyclooxygenase-2 inhibitor
MX2017006813A (es)	2018-01-30	Composicion farmaceutica, preparacion y usos de la misma.
WO2008100907A3 (en)	2008-10-09	Fluoride-releasing compositions
WO2009117401A8 (en)	2009-12-10	Compositions for site-specific delivery of imatinib and methods of use
IL192611A0 (en)	2009-02-11	Biologically active composition comprising ethylcellulose
WO2008075320A3 (en)	2008-08-14	Antilipidemic pharmaceutical compositions and process for preparation thereof
TW200727903A (en)	2007-08-01	Stable pharmaceutical compositions of 5, 10 methylenetetrahydrofolate
MY130792A (en)	2007-07-31	17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
UA95224C2 (ru)	2011-07-25	Антацидная фармацевтическая композиция в порошковой форме, фармацевтическое средство, ее содержащее, и способ ее получения
EP4327815A3 (en)	2024-05-22	Probiotics for regulating blood glucose
ATE400262T1 (de)	2008-07-15	Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität
WO2007018588A8 (en)	2008-05-08	Stable pharmaceutical composition comprising linezolid form iv
WO2011141113A3 (de)	2012-01-05	Kombination aus vitamin k und nikotinamid